By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker said Thursday after the close of the market that it expects to report total revenue for the fourth quarter of more than $355 million.

The updated preliminary results follow its Jan. 13 announcement, when the company had said that revenues for the quarter would be greater than $340 million. GAAP operating margin for Bruker Scientfic Instruments is now projected to exceed 18 percent, the company added. However, it did not provide a revenue figure.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.